Wilkinson Samuel T, Stefanovics Elina, Rosenheck Robert A
Department of Psychiatry, Yale School of Medicine, 300 George St, STE 901, New Haven, CT 06511
J Clin Psychiatry. 2015 Sep;76(9):1174-80. doi: 10.4088/JCP.14m09475.
An increasing number of states have approved posttraumatic stress disorder (PTSD) as a qualifying condition for medical marijuana, although little evidence exists evaluating the effect of marijuana use in PTSD. We examined the association between marijuana use and PTSD symptom severity in a longitudinal, observational study.
From 1992 to 2011, veterans with DSM-III/-IV PTSD (N = 2,276) were admitted to specialized Veterans Affairs treatment programs, with assessments conducted at intake and 4 months after discharge. Subjects were classified into 4 groups according to marijuana use: those with no use at admission or after discharge ("never-users"), those who used at admission but not after discharge ("stoppers"), those who used at admission and after discharge ("continuing users"), and those using after discharge but not at admission ("starters"). Analyses of variance compared baseline characteristics and identified relevant covariates. Analyses of covariance then compared groups on follow-up measures of PTSD symptoms, drug and alcohol use, violent behavior, and employment.
After we adjusted for relevant baseline covariates, marijuana use was significantly associated with worse outcomes in PTSD symptom severity (P < .01), violent behavior (P < .01), and measures of alcohol and drug use (P < .01) when compared with stoppers and never-users. At follow-up, stoppers and never-users had the lowest levels of PTSD symptoms (P < .0001), and starters had the highest levels of violent behavior (P < .0001). After adjusting for covariates and using never-users as a reference, starting marijuana use had an effect size on PTSD symptoms of +0.34 (Cohen d = change/SD), and stopping marijuana use had an effect size of -0.18.
In this observational study, initiating marijuana use after treatment was associated with worse PTSD symptoms, more violent behavior, and alcohol use. Marijuana may actually worsen PTSD symptoms or nullify the benefits of specialized, intensive treatment. Cessation or prevention of use may be an important goal of treatment.
越来越多的州已批准将创伤后应激障碍(PTSD)列为医用大麻的适用病症,尽管几乎没有证据评估使用大麻对PTSD的影响。我们在一项纵向观察性研究中,考察了大麻使用与PTSD症状严重程度之间的关联。
1992年至2011年期间,患有DSM-III/-IV PTSD的退伍军人(N = 2276)被纳入专门的退伍军人事务治疗项目,并在入院时和出院后4个月进行评估。根据大麻使用情况,将受试者分为4组:入院时和出院后均未使用者(“从未使用者”)、入院时使用但出院后未使用者(“停用者”)、入院时和出院后均使用者(“持续使用者”),以及出院后使用但入院时未使用者(“开始使用者”)。方差分析比较了基线特征并确定了相关协变量。然后,协方差分析在PTSD症状、药物和酒精使用、暴力行为及就业的随访指标上对各组进行了比较。
在对相关基线协变量进行调整后,与停用者和从未使用者相比,使用大麻与PTSD症状严重程度(P < 0.01)、暴力行为(P < 0.01)以及酒精和药物使用指标(P < 0.01)的更差结果显著相关。在随访时,停用者和从未使用者的PTSD症状水平最低(P < 0.0001),而开始使用者的暴力行为水平最高(P < 0.0001)。在对协变量进行调整并以从未使用者作为参照后,开始使用大麻对PTSD症状的效应量为+0.34(科恩d = 变化/标准差),停止使用大麻的效应量为-0.18。
在这项观察性研究中,治疗后开始使用大麻与更差的PTSD症状、更多的暴力行为以及酒精使用相关。大麻实际上可能会加重PTSD症状或抵消专门强化治疗的益处。停止或预防使用大麻可能是治疗的一个重要目标。